Calendar

Date TBD

RECRUITINGphase readoutNCT07185191: Evaluation of the Safety and Performance of the Medical Device RDM36 in the Treatment of Periodontal Gingival Contraction and in Black Triangles Syndrome (BTS)

Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Black Triangles Syndrome (BTS), Periodontal Gingival Contraction

full page →ctgov ↗

COMPLETEDphase readoutNCT07052890: Curcumin, Vitamin D and Green Tea in IBS-D

Sponsor: Dr Anthony Hobson. Phase: NA. Conditions: Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome With Diarrhea (IBS-D)

full page →ctgov ↗

RECRUITINGphase readoutNCT05960890: Cohort Study of Chronic Heart Failure

Sponsor: Jiangsu Taizhou People's Hospital. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗

COMPLETEDphase readoutNCT04593810: Effect of Automated Closed-Loop Ventilation Versus Conventional Ventilation on Duration and Quality of Ventilation

Sponsor: Prof. Dr. Marcus J. Schultz. Phase: NA. Conditions: Ventilator-free Days, Quality of Breathing

full page →ctgov ↗

COMPLETEDphase readoutNCT02213913: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Progressive Hairy Cell Leukemia, Initial Treatment, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage 0 Chronic Lymphocytic Leukemia, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Small Lymphocytic Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia

COMPLETEDphase readoutNCT05911360: A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

Sponsor: ViiV Healthcare. Phase: PHASE3. Conditions: HIV, HIV Infections

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07498660: PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Osteoarthitis, Sacro Iliac Joint Pain, Hip Arthroplasty, Total, Sacro-Iliac Spondylosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07684820: To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Sponsor: Expedition Therapeutics, Inc. Phase: PHASE2. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02629120: High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Chronic Granulomatous Disease Transplant

full page →ctgov ↗

RECRUITINGphase readoutNCT07310420: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

Sponsor: TerSera Therapeutics LLC. Phase: PHASE1. Conditions: Advanced Breast Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07617220: FIRST-Sask Study Protocol: A Remote Exercise Oncology Intervention

Sponsor: University of Saskatchewan. Phase: NA. Conditions: Exercise Oncology

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07399782: Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea

Sponsor: Hospital Felicio Rocho. Phase: PHASE2. Conditions: Sleep Apnea Syndrome, Obstructive, Sleep Apnea Syndrome (OSAS), Sleep Apnea/Hypopnea Syndrome, Sleep Apnea - Obstructive

full page →ctgov ↗

COMPLETEDphase readoutNCT07202182: Creative Drama-Based Stress Management Program on Stress, Coping, and Emotional Intelligence

Sponsor: Gazi University. Phase: NA. Conditions: Emotional Intelligence, Creative Drama, Coping, Nursing, Undergraduate

full page →ctgov ↗

RECRUITINGphase readoutNCT06239259: Validity and Reliability of Thai Version Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome

Sponsor: Siriraj Hospital. Phase: . Conditions: Carpal Tunnel Syndrome

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07575659: Early Intervention in Cerebral Palsy: Perception-Action vs Neurodevelopmental Therapy

Sponsor: Tuba Derya Doğan. Phase: NA. Conditions: Cerebral Palsy, Cerebral Palsy Early Intervention

full page →ctgov ↗

RECRUITINGphase readoutNCT06048159: Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Stroke, Aphasia

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07743359: Enhancing Delivery of Parenting Support Within a Peer Recovery Support Service Model

Sponsor: Baystate Medical Center. Phase: NA. Conditions: Substance Use Disorders (SUDs)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07275580: Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases

Sponsor: University of Sao Paulo General Hospital. Phase: PHASE4. Conditions: Autoimmune Rheumatic Diseases, Tooth Extraction, Infection Prevention, Antibiotic Prophylaxis

full page →ctgov ↗

RECRUITINGphase readoutNCT06629779: A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Sponsor: Pfizer. Phase: PHASE3. Conditions: Metastatic Castration-Resistant Prostate Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06095596: Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: NA. Conditions: Ulcerative Colitis (UC)

full page →ctgov ↗

RECRUITINGphase readoutNCT07581496: T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer

Sponsor: University Hospital, Basel, Switzerland. Phase: . Conditions: Bladder Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06857279: A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Sponsor: Shanghai Henlius Biotech. Phase: PHASE2. Conditions: Carcinoma of Head and/or Neck

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06433596: Autologous PRP and Focal Shock Waves for Erectile Dysfunction

Sponsor: Elexial Research Limited. Phase: NA. Conditions: Erectile Dysfunction

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07438262: The AminoECMO Pilot Trial

Sponsor: Australian and New Zealand Intensive Care Research Centre. Phase: PHASE2. Conditions: Acute Kidney Injury

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03997162: Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

Sponsor: City of Hope Medical Center. Phase: . Conditions: Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Pathologic Stage 0 Gastric Cancer AJCC v8, Pathologic Stage I Gastric Cancer AJCC v8, Pathologic Stage IA Gastric Cancer AJCC v8, Pathologic Stage IB Gastric Cancer AJCC v8, Pathologic Stage II Gastric Cancer AJCC v8, Pathologic Stage IIA Gastric Cancer AJCC v8, Pathologic Stage IIB Gastric Cancer AJCC v8, Pathologic Stage III Gastric Cancer AJCC v8, Pathologic Stage IIIA Gastric Cancer AJCC v8, Pathologic Stage IIIB Gastric Cancer AJCC v8, Pathologic Stage IIIC Gastric Cancer AJCC v8

full page →ctgov ↗

COMPLETEDphase readoutNCT05393362: Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.

Sponsor: University of Malaga. Phase: NA. Conditions: Heart Failure With Preserved Ejection Fraction, Sarcopenia, Frail Elderly Syndrome, Comorbidities and Coexisting Conditions

full page →ctgov ↗

COMPLETEDphase readoutNCT05598788: Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies

Sponsor: Rennes University Hospital. Phase: . Conditions: Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib

full page →ctgov ↗

RECRUITINGphase readoutNCT07747103: An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.

Sponsor: Neuvosyn Laboratories, LLC. Phase: PHASE3. Conditions: Hypothyroidism

full page →ctgov ↗

RECRUITINGphase readoutNCT06218303: Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Sponsor: Finn, Olivera, PhD. Phase: PHASE1. Conditions: Ductal Carcinoma in Situ

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07696403: Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose

Sponsor: University of Georgia. Phase: NA. Conditions: Nutrition, Healthy, Dyslipidemia, Overweight and Obesity

full page →ctgov ↗

COMPLETEDphase readoutNCT03985527: Janus Feasibility Study

Sponsor: Respicardia, Inc.. Phase: NA. Conditions: Sleep Apnea Syndromes

full page →ctgov ↗

COMPLETEDphase readoutNCT06111027: Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Spasmodic Dysphonia, Laryngeal Dystonia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05074927: Pulmonary Function in Patients Recovering From COVID19 Infection : a Pilot Study

Sponsor: University Hospital, Limoges. Phase: NA. Conditions: COVID-19

full page →ctgov ↗

COMPLETEDphase readoutNCT02553447: Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

Sponsor: University of Nebraska. Phase: NA. Conditions: Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Untreated Chronic Lymphocytic Leukemia, Vitamin D Deficiency

full page →ctgov ↗

RECRUITINGphase readoutNCT05612347: Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Colorectal Polyp, Colorectal Neoplasms, Colorectal Adenoma, Colorectal Cancer, Digestive System Disease

full page →ctgov ↗

TERMINATEDphase readoutNCT05754749: Comparison of CE-DBT and MRI in Patients With Known Breast Lesions

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Breast Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT03716349: Esthetics of Dental Composite and Adhesive System

Sponsor: Erica Teixeira. Phase: NA. Conditions: Cavities of Teeth

full page →ctgov ↗

RECRUITINGphase readoutNCT06144749: A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Sponsor: Hillhurst Biopharmaceuticals, Inc.. Phase: PHASE1. Conditions: Anemia, Sickle Cell

full page →ctgov ↗

COMPLETEDphase readoutNCT05693038: Brachial Plexus Injury After Prone Positioning

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Brachial Plexus Injury, Nerve Compression

full page →ctgov ↗

COMPLETEDphase readoutNCT06782438: Evaluation of an Artificial Intelligence Algorithm Reducing Noise on Fast Whole-body Bone Tomoscintigraphy Acquisitions Recorded by a 360 Degree Cadmium-Zinc-Tellurid Camera

Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Bone Scan

full page →ctgov ↗

RECRUITINGphase readoutNCT05209438: Cereset Research for Caregivers

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Caregivers

full page →ctgov ↗

RECRUITINGphase readoutNCT07221838: A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE4. Conditions: Generalized Myasthenia Gravis, gMG

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06062238: Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults

Sponsor: Gates Medical Research Institute. Phase: PHASE3. Conditions: Tuberculosis

full page →ctgov ↗

COMPLETEDphase readoutNCT07747038: Caudal Block v/s Local Wound Infiltration for Pain Control in Pediatric Patients After Operation for Inguinal Hernia

Sponsor: Fatima Memorial Hospital. Phase: NA. Conditions: Postoperative Pain

full page →ctgov ↗

RECRUITINGphase readoutNCT07658638: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants

Sponsor: Tes Pharma S.r.l.. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗

RECRUITINGphase readoutNCT07292038: Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors

Sponsor: NucMito Pharmaceuticals Co. Ltd.. Phase: PHASE1. Conditions: Cancers

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07336238: Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Sponsor: University of Washington. Phase: PHASE2. Conditions: Anxiety, Depression, Hematopoietic and Lymphatic System Neoplasm, Metastatic Malignant Solid Neoplasm

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07223138: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

Sponsor: MoonLake Immunotherapeutics AG. Phase: PHASE3. Conditions: Arthritis, Psoriatic

full page →ctgov ↗

COMPLETEDphase readoutNCT02926547: New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement

Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Breast Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05358249: Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Colorectal Cancer, Colorectal Carcinoma, Colorectal Neoplasms, Colorectal Tumors, Neoplasms, Colorectal

full page →ctgov ↗

Date TBD